National Center for Tumor Diseases (NCT)
The National Center for Tumor Diseases (NCT) is a long-term cooperation between the German Cancer Research Center (DKFZ), excellent partners in university medicine and other outstanding research partners at various locations in Germany.
Heidelberg has been the first NCT site since 2004, Dresden the second site since 2015. On February 2, 2023, the BMBF announced the new sites: Berlin, SüdWest (Tübingen/Stuttgart-Ulm), WERA (Würzburg with partners Erlangen, Regensburg and Augsburg) and West (Cologne/Essen). This means that a total of six NCT sites are now cooperating with the German Cancer Research Center (DKFZ) to advance clinical cancer research in Germany and to improve treatment outcomes and the quality of life of cancer patients.